This report contains market size and forecasts of Long Acting Sulfonamide in global, including the following market information:
Global Long Acting Sulfonamide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Long Acting Sulfonamide Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Long Acting Sulfonamide companies in 2021 (%)
The global Long Acting Sulfonamide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intestinal Absorption Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Long Acting Sulfonamide include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long Acting Sulfonamide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long Acting Sulfonamide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Long Acting Sulfonamide Market Segment Percentages, by Type, 2021 (%)
Intestinal Absorption
Intestinal Tract Difficult to Absorb
External Use
Global Long Acting Sulfonamide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Long Acting Sulfonamide Market Segment Percentages, by Application, 2021 (%)
Systemic Infection
Intestinal Infection
Burn Infection
Other Infections
Global Long Acting Sulfonamide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Long Acting Sulfonamide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Long Acting Sulfonamide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Long Acting Sulfonamide revenues share in global market, 2021 (%)
Key companies Long Acting Sulfonamide sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Long Acting Sulfonamide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
Roche
Mylan
Teva
Bayer
Abbott
GlaxoSmithKline
Boehringer Ingelheim